Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CYP51A1 inhibitors(Cytochrome P450 51 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H21ClF3N3O |
InChIKeyOJFZYAQGMWSUID-QFIPXVFZSA-N |
CAS Registry1486506-92-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acanthamoeba Keratitis | Preclinical | US | 29 Apr 2024 |